Related Experiment Videos
Shift from polyploidizing to nonpolyploidizing growth in carcinogen-treated rat liver.
G Saeter1, E Schwarze, O Seglen
1Department of Tissue Culture, Institute for Cancer Research, Norwegian Radium Hospital, Oslo.
Journal of the National Cancer Institute
|August 17, 1988
Summary
Normal liver development involves polyploidizing growth. Carcinogen treatment, however, can induce nonpolyploidizing growth, potentially by promoting diploid hepatocyte proliferation, impacting liver cancer research.
Area of Science:
- Hepatology
- Cell Biology
- Toxicology
Background:
- Liver growth involves complex changes in hepatocyte number and ploidy.
- Understanding these patterns is crucial for studying liver development and disease, including cancer.
- Carcinogen exposure can alter normal liver growth mechanisms.
Purpose of the Study:
- To analyze liver growth patterns in normal and carcinogen-treated rats.
- To differentiate between polyploidizing and nonpolyploidizing growth modes.
- To investigate the role of diploid hepatocyte proliferation in carcinogen-induced liver changes.
Main Methods:
- DNA measurements using flow cytometry.
- Microscope counts of binucleated cells.
- Analysis of absolute hepatocyte numbers and ploidy distributions in Wistar Kyoto rats.
Main Results:
- Normal liver development showed progressive polyploidization and decreased diploid cells.
- Liver regeneration and 2-acetylaminofluorene (AAF) treatment induced nonpolyploidizing growth.
- Diethylnitrosamine initiation followed by AAF promotion led to sustained diploid hepatocyte proliferation.
Conclusions:
- Liver growth can occur via distinct polyploidizing and nonpolyploidizing pathways.
- AAF-promoted diploid hepatocyte expansion may arise from diethylnitrosamine-altered cells.
- These findings offer insights into mechanisms of chemical carcinogenesis and liver regeneration.